Literature DB >> 1433528

TAR-independent replication of human immunodeficiency virus type 1 in glial cells.

O Bagasra1, K Khalili, T Seshamma, J P Taylor, R J Pomerantz.   

Abstract

The molecular mechanisms involved in the replication of human immunodeficiency virus type 1 (HIV-1) may differ in various cell types and with various exogenous stimuli. Astrocytic glial cells, which can support HIV-1 replication in cell cultures and may be infected in vivo, are demonstrated to provide a cellular milieu in which TAR mutant HIV-1 viruses may replicate. Using transfections of various TAR mutant HIV-1 proviral constructs, we demonstrate TAR-independent replication in unstimulated astrocytic cells. We further demonstrate, using viral constructs with mutations in the tat gene and in the nuclear factor kappa B (NF-kappa B)-binding sites (enhancer) of the HIV-1 long terminal repeat, that TAR-independent HIV-1 replication in astrocytic cells requires both intact NF-kappa B moiety-binding motifs in the HIV-1 long terminal repeat and Tat expression. We measured HIV-1 p24 antigen production, syncytium formation, and levels and patterns of viral RNA expression by Northern (RNA) blotting to characterize TAR-independent HIV-1 expression in astrocytic glial cells. This alternative regulatory pathway of TAR-independent, Tat-responsive viral production may be important in certain cell types for therapies which seek to perturb Tat-TAR binding as a strategy to interrupt the viral lytic cycle.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1433528      PMCID: PMC240462     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  52 in total

Review 1.  NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control.

Authors:  M J Lenardo; D Baltimore
Journal:  Cell       Date:  1989-07-28       Impact factor: 41.582

2.  HIV-1 Tat acts as a processivity factor in vitro in conjunction with cellular elongation factors.

Authors:  H Kato; H Sumimoto; P Pognonec; C H Chen; C A Rosen; R G Roeder
Journal:  Genes Dev       Date:  1992-04       Impact factor: 11.361

3.  Brain-derived cells can be infected with HIV isolates derived from both blood and brain.

Authors:  B Keys; J Albert; J Kövamees; F Chiodi
Journal:  Virology       Date:  1991-08       Impact factor: 3.616

4.  Functional roles for the TATA promoter and enhancers in basal and Tat-induced expression of the human immunodeficiency virus type 1 long terminal repeat.

Authors:  B Berkhout; K T Jeang
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

5.  The role of mononuclear phagocytes in HTLV-III/LAV infection.

Authors:  S Gartner; P Markovits; D M Markovitz; M H Kaplan; R C Gallo; M Popovic
Journal:  Science       Date:  1986-07-11       Impact factor: 47.728

6.  Establishment of human glial cell lines chronically infected with the human immunodeficiency virus.

Authors:  S Dewhurst; K Sakai; X H Zhang; A Wasiak; D J Volsky
Journal:  Virology       Date:  1988-01       Impact factor: 3.616

7.  Immunohistochemical identification of HTLV-III antigen in brains of patients with AIDS.

Authors:  D H Gabuzda; D D Ho; S M de la Monte; M S Hirsch; T R Rota; R A Sobel
Journal:  Ann Neurol       Date:  1986-09       Impact factor: 10.422

8.  Infection of human brain cells by HIV-1: restricted virus production in chronically infected human glial cell lines.

Authors:  R Brack-Werner; A Kleinschmidt; A Ludvigsen; W Mellert; M Neumann; R Herrmann; M C Khim; A Burny; N Müller-Lantzsch; D Stavrou
Journal:  AIDS       Date:  1992-03       Impact factor: 4.177

9.  Efficient replication of human immunodeficiency virus type 1 requires a threshold level of Rev: potential implications for latency.

Authors:  R J Pomerantz; T Seshamma; D Trono
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

10.  TAR-independent transactivation by Tat in cells derived from the CNS: a novel mechanism of HIV-1 gene regulation.

Authors:  J P Taylor; R Pomerantz; O Bagasra; M Chowdhury; J Rappaport; K Khalili; S Amini
Journal:  EMBO J       Date:  1992-09       Impact factor: 11.598

View more
  17 in total

1.  Human immunodeficiency virus tat gene transfer to the murine central nervous system using a replication-defective herpes simplex virus vector stimulates transforming growth factor beta 1 gene expression.

Authors:  S Rasty; P Thatikunta; J Gordon; K Khalili; S Amini; J C Glorioso
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

2.  The HIV-1 Tat protein has a versatile role in activating viral transcription.

Authors:  Atze T Das; Alex Harwig; Ben Berkhout
Journal:  J Virol       Date:  2011-07-13       Impact factor: 5.103

3.  Optimal Tat-mediated activation of the HIV-1 LTR promoter requires a full-length TAR RNA hairpin.

Authors:  K Verhoef; M Tijms; B Berkhout
Journal:  Nucleic Acids Res       Date:  1997-02-01       Impact factor: 16.971

4.  Extracellular human immunodeficiency virus type 1 Tat protein is associated with an increase in both NF-kappa B binding and protein kinase C activity in primary human astrocytes.

Authors:  K Conant; M Ma; A Nath; E O Major
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

5.  In vivo selection of randomly mutated retroviral genomes.

Authors:  B Berkhout; B Klaver
Journal:  Nucleic Acids Res       Date:  1993-11-11       Impact factor: 16.971

6.  Role of β-catenin and TCF/LEF family members in transcriptional activity of HIV in astrocytes.

Authors:  Srinivas D Narasipura; Lisa J Henderson; Sidney W Fu; Liang Chen; Fatah Kashanchi; Lena Al-Harthi
Journal:  J Virol       Date:  2011-12-07       Impact factor: 5.103

7.  Central nervous system-derived cells express a kappa B-binding activity that enhances human immunodeficiency virus type 1 transcription in vitro and facilitates TAR-independent transactivation by Tat.

Authors:  J P Taylor; R J Pomerantz; G V Raj; F Kashanchi; J N Brady; S Amini; K Khalili
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

Review 8.  Human immunodeficiency virus infection of the brain: pitfalls in evaluating infected/affected cell populations.

Authors:  Stephanie J Bissel; Clayton A Wiley
Journal:  Brain Pathol       Date:  2004-01       Impact factor: 6.508

9.  HIV-1 Tat mediates degradation of RON receptor tyrosine kinase, a regulator of inflammation.

Authors:  Parisa Kalantari; Omid F Harandi; Pamela A Hankey; Andrew J Henderson
Journal:  J Immunol       Date:  2008-07-15       Impact factor: 5.422

10.  A model system for human cytomegalovirus-mediated modulation of human immunodeficiency virus type 1 long terminal repeat activity in brain cells.

Authors:  T N Moreno; E A Fortunato; K Hsia; S A Spector; D H Spector
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.